Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Senseonics HoldingsSENS +2.09%73 12-1 Month Momentum % is -4.57% as of Sep. 22, 2026. GuruFocus rates SENS with a GF Score™ of 73/100 and a GF Value™ of $12.23 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 830 Medical Devices & Instruments companies, Senseonics Holdings ranks better than 64.46% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-22), Senseonics Holdings's 12-1 Month Momentum % is -4.57%.
The industry rank for Senseonics Holdings's 12-1 Month Momentum % or its related term are showing as below:
SENS's 12-1 Month Momentum % is ranked better than 64.46% of 830
companies
in the Medical Devices & Instruments industry
Industry Median: -17.66
vs SENS: -4.57
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Senseonics Holdings 12-1 Month Momentum % Related Terms
SENS vs NPCE, CLPT, SGHT: 12-1 Month Momentum % Comparison
For the Medical Devices subindustry, Senseonics Holdings's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senseonics Holdings 12-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Senseonics Holdings's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Senseonics Holdings (SENS) has a 12-1 Month Momentum % of -4.57% as of Sep. 22, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Senseonics Holdings and its competitors. According to the industry distribution chart, Senseonics Holdings ranks #295 out of 830 companies in the Medical Devices & Instruments industry, placing it in the top 35.5%.
Is Senseonics Holdings' 12-1 Month Momentum % too high?
Senseonics Holdings' current 12-1 Month Momentum % is -4.57%. Based on the distribution chart, Senseonics Holdings ranks #295 out of 830 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Senseonics Holdings has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' 12-1 Month Momentum % compare to NPCE and CLPT?
According to the Medical Devices & Instruments industry distribution chart, Senseonics Holdings ranks #295 out of 830 companies for 12-1 Month Momentum %. This puts Senseonics Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Devices & Instruments company?
A good 12-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Senseonics Holdings and its competitors. Senseonics Holdings's current 12-1 Month Momentum % is -4.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Modestly Undervalued. The stock's GF Value™ is $12.23, compared to a current price of $9.78 — trading 20% below its estimated fair value. The current 12-1 Month Momentum % is -4.57%. Senseonics Holdings' overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current 12-1 Month Momentum % is -4.57% as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Senseonics Holdings (SENS) Overvalued in 2026?
Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued.
The current stock price of $9.78 is trading 20% below its estimated GF Value™ of $12.23.
GuruFocus considers Senseonics Holdings to be Modestly Undervalued.
Key valuation signals for SENS:
12-1 Month Momentum %: -4.57%
GF Value™: $12.23 vs. price of $9.78 (20% below fair value)
No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
73GF Score
Get the complete analysis for SENS
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SENS has been successfully added to your 
